Covenant Health Oncology Group - Maryville — Maryville, Tennessee

Covenant Health Oncology Group - Maryville is a clinical research site located in Maryville, Tennessee, United States 37804.

Crixeo Health Trust Score: 69/100 (FAIR). This profile has not yet been claimed by the site owner.

Covenant Health Oncology Group - Maryville has participated in 6 clinical trials with 6 currently active.

Therapeutic areas: Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8.

Sponsors: NRG Oncology, National Cancer Institute (NCI).

Sponsor Feasibility Report

Trust Score: 69/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Covenant Health Oncology Group - Maryville?

Covenant Health Oncology Group - Maryville has a Crixeo Trust Score of 69/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Covenant Health Oncology Group - Maryville conducted?

Covenant Health Oncology Group - Maryville has 6 clinical trials on record, with 6 currently active. Their work covers Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8.

Is Covenant Health Oncology Group - Maryville accredited by Crixeo Health?

Covenant Health Oncology Group - Maryville has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Covenant Health Oncology Group - Maryville?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.